Point Nemo Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Point Nemo Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.35M	Buy	+5,810	New	+$1.44M	0.63%	61

Other funds holding JAZZ

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Point Nemo Capital's JAZZ Position: Q3 2026 in Review

Point Nemo Capital opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 5,810 shares worth $1.35M. The stake represents 0.63% of the portfolio and ranks #61 among its holdings.

331 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Point Nemo Capital held 5,810 shares of Jazz Pharmaceuticals worth $1.35M as of Q3 2026.
Jazz Pharmaceuticals was a new Point Nemo Capital position in Q3 2026.
Jazz Pharmaceuticals made up 0.63% of Point Nemo Capital's portfolio in Q3 2026, its #61 holding.
331 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Point Nemo Capital's 13F filing for Q3 2026, filed 3 Nov 2026.